Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 30

Cited In for PubMed (Select 11027218)

1.

Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology.

Guillot-Sestier MV, Doty KR, Gate D, Rodriguez J Jr, Leung BP, Rezai-Zadeh K, Town T.

Neuron. 2015 Feb 4;85(3):534-48. doi: 10.1016/j.neuron.2014.12.068. Epub 2015 Jan 22.

PMID:
25619654
2.

Microglial activation mediates host neuronal survival induced by neural stem cells.

Wu HM, Zhang LF, Ding PS, Liu YJ, Wu X, Zhou JN.

J Cell Mol Med. 2014 Jul;18(7):1300-12. doi: 10.1111/jcmm.12281. Epub 2014 Apr 13.

3.

The role of the innate immune system in Alzheimer's disease and frontotemporal lobar degeneration: an eye on microglia.

Ridolfi E, Barone C, Scarpini E, Galimberti D.

Clin Dev Immunol. 2013;2013:939786. doi: 10.1155/2013/939786. Epub 2013 Jul 18. Review.

4.

Innate immunity in Alzheimer's disease: a complex affair.

Guillot-Sestier MV, Town T.

CNS Neurol Disord Drug Targets. 2013 Aug;12(5):593-607. Review.

5.

Ferulic acid is a nutraceutical β-secretase modulator that improves behavioral impairment and alzheimer-like pathology in transgenic mice.

Mori T, Koyama N, Guillot-Sestier MV, Tan J, Town T.

PLoS One. 2013;8(2):e55774. doi: 10.1371/journal.pone.0055774. Epub 2013 Feb 8.

6.

HIV-1 Tat-induced microglial activation and neuronal damage is inhibited via CD45 modulation: A potential new treatment target for HAND.

Jin J, Lam L, Sadic E, Fernandez F, Tan J, Giunta B.

Am J Transl Res. 2012;4(3):302-15. Epub 2012 Jul 22.

7.

Small molecule tools for functional interrogation of protein tyrosine phosphatases.

He R, Zeng LF, He Y, Zhang S, Zhang ZY.

FEBS J. 2013 Jan;280(2):731-50. doi: 10.1111/j.1742-4658.2012.08718.x. Epub 2012 Aug 16. Review.

8.

Microglia in Alzheimer's Disease: It's All About Context.

Weitz TM, Town T.

Int J Alzheimers Dis. 2012;2012:314185. doi: 10.1155/2012/314185. Epub 2012 Jun 20.

9.

Neuroimmune crosstalk in the central nervous system and its significance for neurological diseases.

Tian L, Ma L, Kaarela T, Li Z.

J Neuroinflammation. 2012 Jul 2;9:155. doi: 10.1186/1742-2094-9-155. Review.

10.
11.

Inhibition of Src kinase activity attenuates amyloid associated microgliosis in a murine model of Alzheimer's disease.

Dhawan G, Combs CK.

J Neuroinflammation. 2012 Jul 2;9:117. doi: 10.1186/1742-2094-9-117.

12.

Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE-1 in a transgenic model of Alzheimer's disease-like amyloid pathology.

Ferretti MT, Allard S, Partridge V, Ducatenzeiler A, Cuello AC.

J Neuroinflammation. 2012 Apr 2;9:62. doi: 10.1186/1742-2094-9-62.

13.

Alzheimer's Disease: Fatty Acids We Eat may be Linked to a Specific Protection via Low-dose Aspirin.

Pomponi MF, Gambassi G, Pomponi M, Masullo C.

Aging Dis. 2010 Aug;1(1):37-59. Epub 2010 Jul 12.

14.

Tannic acid is a natural β-secretase inhibitor that prevents cognitive impairment and mitigates Alzheimer-like pathology in transgenic mice.

Mori T, Rezai-Zadeh K, Koyama N, Arendash GW, Yamaguchi H, Kakuda N, Horikoshi-Sakuraba Y, Tan J, Town T.

J Biol Chem. 2012 Feb 24;287(9):6912-27. doi: 10.1074/jbc.M111.294025. Epub 2012 Jan 4.

15.

Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells.

Basha G, Novobrantseva TI, Rosin N, Tam YY, Hafez IM, Wong MK, Sugo T, Ruda VM, Qin J, Klebanov B, Ciufolini M, Akinc A, Tam YK, Hope MJ, Cullis PR.

Mol Ther. 2011 Dec;19(12):2186-200. doi: 10.1038/mt.2011.190. Epub 2011 Oct 4.

16.

CD45 deficiency drives amyloid-β peptide oligomers and neuronal loss in Alzheimer's disease mice.

Zhu Y, Hou H, Rezai-Zadeh K, Giunta B, Ruscin A, Gemma C, Jin J, Dragicevic N, Bradshaw P, Rasool S, Glabe CG, Ehrhart J, Bickford P, Mori T, Obregon D, Town T, Tan J.

J Neurosci. 2011 Jan 26;31(4):1355-65. doi: 10.1523/JNEUROSCI.3268-10.2011.

17.

Flipping the switches: CD40 and CD45 modulation of microglial activation states in HIV associated dementia (HAD).

Salemi J, Obregon DF, Cobb A, Reed S, Sadic E, Jin J, Fernandez F, Tan J, Giunta B.

Mol Neurodegener. 2011 Jan 11;6(1):3. doi: 10.1186/1750-1326-6-3.

18.

Deletion of CD14 attenuates Alzheimer's disease pathology by influencing the brain's inflammatory milieu.

Reed-Geaghan EG, Reed QW, Cramer PE, Landreth GE.

J Neurosci. 2010 Nov 17;30(46):15369-73. doi: 10.1523/JNEUROSCI.2637-10.2010.

19.

Heterogeneity of microglial activation in the innate immune response in the brain.

Colton CA.

J Neuroimmune Pharmacol. 2009 Dec;4(4):399-418. doi: 10.1007/s11481-009-9164-4. Epub 2009 Aug 5. Review.

20.

Alternative Abeta immunotherapy approaches for Alzheimer's disease.

Town T.

CNS Neurol Disord Drug Targets. 2009 Apr;8(2):114-27. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk